Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y
about
Uncertainties in the classification of human cationic trypsinogen (PRSS1) variants as hereditary pancreatitis-associated mutationsChymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitisHereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanismCaldecrin: A pancreas-derived hypocalcemic factor, regulates osteoclast formation and functionFramework for interpretation of trypsin-antitrypsin imbalance and genetic heterogeneity in pancreatitisGenetics of pancreatitisPancreatic cancer risk in hereditary pancreatitisLong-range Electrostatic Complementarity Governs Substrate Recognition by Human Chymotrypsin C, a Key Regulator of Digestive Enzyme ActivationChymotrypsin C mutations in chronic pancreatitis.A conservative assessment of the major genetic causes of idiopathic chronic pancreatitis: data from a comprehensive analysis of PRSS1, SPINK1, CTRC and CFTR genes in 253 young French patientsPancreatitis-associated chymotrypsinogen C (CTRC) mutant elicits endoplasmic reticulum stress in pancreatic acinar cellsGenetic Risk in Chronic Pancreatitis: The Trypsin-Dependent Pathway.High affinity small protein inhibitors of human chymotrypsin C (CTRC) selected by phage display reveal unusual preference for P4' acidic residues.Chymotrypsin C is a co-activator of human pancreatic procarboxypeptidases A1 and A2.Genetics of acute and chronic pancreatitis: An update.Genetic and phenotypic heterogeneity in tropical calcific pancreatitisGene conversion between cationic trypsinogen (PRSS1) and the pseudogene trypsinogen 6 (PRSS3P2) in patients with chronic pancreatitis.Chymotrypsin C (caldecrin) is associated with enamel developmentThe Common Chymotrypsinogen C (CTRC) Variant G60G (C.180T) Increases Risk of Chronic Pancreatitis But Not Recurrent Acute Pancreatitis in a North American Population.Mesotrypsin Signature Mutation in a Chymotrypsin C (CTRC) Variant Associated with Chronic Pancreatitis.Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin CGlycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteinsCTRC gene polymorphism (p.G60=; c.180 C > T) in acute pancreatitis.Pathogenic cellular role of the p.L104P human cationic trypsinogen variant in chronic pancreatitisFunctional effects of 13 rare PRSS1 variants presumed to cause chronic pancreatitis.Genetic risk factors for pancreatic disorders.Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.Autoactivation of mouse trypsinogens is regulated by chymotrypsin C via cleavage of the autolysis loop.Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia.Molecular basis for pancreatitis.Zymogen activation confers thermodynamic stability on a key peptide bond and protects human cationic trypsin from degradation.Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis.Human trypsinogens in the pancreas and in cancer.Association of CTRC and SPINK1 gene variants with recurrent hospitalizations for pancreatitis or acute abdominal pain in lipoprotein lipase deficiencyProteomic analysis of zymogen granules.Genetics of pancreatitis: a guide for clinicians.Genetics of acute and chronic pancreatitis.Identification of a functional enhancer variant within the chronic pancreatitis-associated SPINK1 c.101A>G (p.Asn34Ser)-containing haplotype.Complex Formation of Human Proelastases with Procarboxypeptidases A1 and A2.Asparagine-linked glycosylation of human chymotrypsin C is required for folding and secretion but not for enzyme activity.
P2860
Q24620760-78814A2C-4A2D-4594-9DAB-DA65F74AED3BQ24645261-6CD303A1-7DF6-4781-BFE2-E7B086AEA0BBQ24650338-1E31CF4B-07BF-4FFF-B14B-1F571D2A9CE1Q26775406-C5321863-EDC8-4FD3-A78A-2034ADB7DF0BQ26801332-AC9E3906-AD34-494F-A915-54705F0656E3Q27000406-2EE2D8FC-4B3F-4C82-8D71-4CA1CB23F664Q27003930-965C5529-7D9E-4F6E-A3E8-4CD209C849FBQ27676497-E00ED3EC-2283-4C1E-BC82-2FA95CB81C42Q27693296-0BF74660-D39A-4257-9CCC-5E9526C98221Q30000783-F8F0C661-341F-4CBB-94E1-47239BB57202Q33764920-9EB3808C-14CE-4F37-853B-6D200BACF179Q33843764-A82C0B23-028B-4B91-B579-6A89A1D7F32DQ33880616-3F742C28-E0EA-4733-93C9-9E774BF092B2Q34503091-FE82D4D6-0265-43A2-8F7F-602E942DE55BQ34508844-4C825C19-04F7-49D3-89D0-700EFAB555C3Q34667122-81041E9F-7B3C-48A9-A590-ACB5B3D291F7Q35181335-CC2B675F-8B08-42B3-979F-3815795811ADQ35212921-04392650-6342-4206-8829-F0696D72AE91Q35565390-9ADE1840-EBCA-445A-BDBD-DAEA7B2AB6F0Q35837145-3282B5C9-F19C-4812-8DA6-B6A427A8DE2CQ36016998-6E9306ED-3060-4576-9DAC-F77D4862B8CCQ36089872-30F539B2-E88E-4B00-96AC-4D777A06DC7AQ36251687-69CBA58C-DFD8-40FE-ACC3-73FFC8EA4301Q36775826-3F89FB08-BC0B-4DAD-B6DA-634288580D86Q36927073-7644095E-4651-450E-A4F2-66F87ACD7F3DQ36933359-E9128544-E6BA-4758-B432-06C45F5FF409Q37065823-99CB7005-A192-4B6A-8F2E-AFC8CBBE478CQ37099760-112D67A4-8843-4F88-BDFC-4B47B60B4F71Q37130123-78DB851D-D3BD-4393-AC5C-C1D0EDE1443FQ37362100-8ACFB5F6-8595-4706-A6A7-DCF1265F5690Q37596314-50726D4D-A718-4F86-859C-D13304AFF7FFQ37629167-F5572B63-C123-4FA8-9E74-F4AE6308C3A5Q37693897-DFB49399-B3C2-4ABC-B42D-67E42B5B30FEQ37725572-B48574FA-8D69-4021-82A2-5A8472904176Q37802876-F396F12E-6A8C-43F0-83BB-96900EB1BF95Q37869759-D1915F5F-9DB6-4D40-87B6-039EAEBB024FQ38122993-CBD12008-4921-4FAE-80C9-FFC95546732AQ38757404-41E10E8F-0F35-4CA5-A047-8428D568AE80Q38760758-CC39CCD1-870F-4E9A-AED3-C735C1BDC947Q38963298-C6AB378A-CBD0-47A9-BF8D-42FB04BC9FD6
P2860
Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Chymotrypsin C (caldecrin) pro ...... y with Rinderknecht's enzyme Y
@ast
Chymotrypsin C (caldecrin) pro ...... y with Rinderknecht's enzyme Y
@en
Chymotrypsin C (caldecrin) pro ...... y with Rinderknecht's enzyme Y
@nl
type
label
Chymotrypsin C (caldecrin) pro ...... y with Rinderknecht's enzyme Y
@ast
Chymotrypsin C (caldecrin) pro ...... y with Rinderknecht's enzyme Y
@en
Chymotrypsin C (caldecrin) pro ...... y with Rinderknecht's enzyme Y
@nl
prefLabel
Chymotrypsin C (caldecrin) pro ...... y with Rinderknecht's enzyme Y
@ast
Chymotrypsin C (caldecrin) pro ...... y with Rinderknecht's enzyme Y
@en
Chymotrypsin C (caldecrin) pro ...... y with Rinderknecht's enzyme Y
@nl
P2860
P356
P1476
Chymotrypsin C (caldecrin) pro ...... y with Rinderknecht's enzyme Y
@en
P2093
Richárd Szmola
P2860
P304
11227-11232
P356
10.1073/PNAS.0703714104
P407
P577
2007-06-25T00:00:00Z